1-4 of 4
Christian Meyer zum Büschenfelde
Close
Sort by
Journal Articles

High-Dose Therapy (HDT) with Melphalan and Autologous Stem Cell Transplantation (ASCT) for Patients Older Than 70 Years with Multiple Myeloma

Hendrik Brockhoff, Christian Meyer zum Büschenfelde, Prof, MD, Murwan Ayoub, MD, Hartmut Goldschmidt, Prof, MD, Hans-Juergen Salwender, MD
Journal: Blood
Blood (2016) 128 (22): 3461.
https://doi.org/10.1182/blood.V128.22.3461.3461
Published: 2016
Journal Articles

Oncogenic JAK2V617F requires an intact SH2-like domain for constitutive activation and induction of a myeloproliferative disease in mice

Sivahari P. Gorantla, Tobias N. Dechow, Rebekka Grundler, Anna Lena Illert, Christian Meyer zum Büschenfelde, Marcus Kremer, Christian Peschel, Justus Duyster
Journal: Blood
Blood (2010) 116 (22): 4600–4611.
https://doi.org/10.1182/blood-2009-07-236133
Published: 2010
Includes: Supplemental data
Journal Articles

Recruitment of PKC-Beta to Lipid Rafts Mediates Apoptosis-Resistance in Chronic Lymphocytic Leukemia Expressing Zap-70.

Ingo Ringshausen, Michaela Wagner, Gloria Lutzny, Madlen Oelsner, Yvonne Feuerstacke, Thomas Decker, Christian Bogner, Christian Peschel, MD, Christian Meyer zum Buschenfelde
Journal: Blood
Blood (2009) 114 (22): 2354.
https://doi.org/10.1182/blood.V114.22.2354.2354
Published: 2009
Journal Articles

Bryostatin Enhances the Cytotoxic Effects of Anti-CD22 Immunotoxins in CLL by Two Distinct Mechanisms: Implications for a Sequential Therapy.

Ingo Ringshausen, Thomas Decker, Viola Biberacher, Christian Meyer zum Buschenfelde, Madlen Oelsner, Michaela Wagner, Christian Bogner, Christian Peschel, MD
Journal: Blood
Blood (2009) 114 (22): 3429.
https://doi.org/10.1182/blood.V114.22.3429.3429
Published: 2009